Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
October 5, 2023
Telemedicine acceptance by older adults in Hong Kong during a hypothetical severe outbreak and after the COVID-19 pandemic: a cross-sectional cohort survey
M C Y Choi, S H Chu, L L Siu, et al.
British Journal of Cancer
|
November 12, 2015
A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium
S Lheureux, A M Oza, S A Laurie, et al.
ESMO Open
|
May 8, 2026
First-in-human study of the dual A<sub>2</sub><sub>A</sub>/A<sub>2</sub><sub>B</sub> adenosine receptor antagonist muvadenant (M1069) in patients with advanced solid tumors
L L Siu, M E Gutierrez, L Pudelko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks
L L Siu, A M Oza, E A Eisenhauer, et al.
British Journal of Cancer
|
March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
C A Townsley, P Major, L L Siu, et al.
British Journal of Cancer
|
February 16, 2013
In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours
M Quintela-Fandino, M Krzyzanowska, G Duncan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 16, 2005
Post-operative radiochemotherapy for gastric cancer: adoption and adaptation
J Ringash, S J Khaksart, A Oza, et al.
British Journal of Cancer
|
January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
A Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, L L Siu, I Gauthier, et al.
British Journal of Cancer
|
February 3, 2011
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
A R A Razak, S J Hotte, L L Siu, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
October 5, 2023
Telemedicine acceptance by older adults in Hong Kong during a hypothetical severe outbreak and after the COVID-19 pandemic: a cross-sectional cohort survey
M C Y Choi, S H Chu, L L Siu, et al.
British Journal of Cancer
|
November 12, 2015
A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium
S Lheureux, A M Oza, S A Laurie, et al.
ESMO Open
|
May 8, 2026
First-in-human study of the dual A<sub>2</sub><sub>A</sub>/A<sub>2</sub><sub>B</sub> adenosine receptor antagonist muvadenant (M1069) in patients with advanced solid tumors
L L Siu, M E Gutierrez, L Pudelko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks
L L Siu, A M Oza, E A Eisenhauer, et al.
British Journal of Cancer
|
March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
C A Townsley, P Major, L L Siu, et al.
British Journal of Cancer
|
February 16, 2013
In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours
M Quintela-Fandino, M Krzyzanowska, G Duncan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 16, 2005
Post-operative radiochemotherapy for gastric cancer: adoption and adaptation
J Ringash, S J Khaksart, A Oza, et al.
British Journal of Cancer
|
January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies
A Spreafico, J-P Delord, L De Mattos-Arruda, et al.
Cancer Chemotherapy and Pharmacology
|
March 11, 2006
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group
G Goss, L L Siu, I Gauthier, et al.
British Journal of Cancer
|
February 3, 2011
Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
A R A Razak, S J Hotte, L L Siu, et al.
Page
of 9